Regulation of DNA Binding By POTI: Potential Drug Targets (G653269)

Target Name: POTEI

NCBI ID: G653269

POTEI

Regulation of DNA Binding By POTI: Potential Drug Targets

Proteins plays a vital role in almost every biological process in the cell. They are the building blocks of life and are involved in almost every cellular function. One of the protein families, known as the POTEI (protein tyrosine kinase-associated with DNA binding), is a key regulator of gene expression and has been implicated in various diseases including cancer, neurodegenerative diseases, and autoimmune disorders.

The POTEI gene family consists of several protein kinases that are involved in the regulation of DNA binding and gene expression. One of the most well-studied proteins in the POTEI family is POTEI (Protein Tyrosine Kinase-Associated with DNA Binding I), also known as POTI (Protein Tyrosine Kinase-Associated with DNA Binding II). POTI is a 21 kDa protein that is predominantly localized to the endoplasmic reticulum (ER) and is involved in the regulation of DNA binding and gene expression.

POTI is a key regulator of gene expression and has been implicated in various diseases including cancer, neurodegenerative diseases, and autoimmune disorders. POTI has been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and transcriptional regulation.

POTI has also been shown to interact with various protein substrates, including histone modifications such as histone H3 lysine 27 (H3K27) modification. H3K27 modification is a well-established modification that plays a role in the regulation of gene expression and has been implicated in various diseases including cancer.

In addition to its role in gene expression, POTI has also been shown to play a role in the regulation of cellular signaling pathways. POTI has been shown to interact with various signaling proteins, including the transcription factor, NF-kappa-B (Nuclear Factor Kappa B), and the protein, heat shock protein (HSP) 70.

POTI has also been shown to play a role in the regulation of cellular transport. POTI has been shown to interact with the protein, TRF2 (Transportational regulator F2), which is involved in the regulation of protein transport in the ER.

Drugs targeting POTI have the potential to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. POTI has also been shown to be a potential drug target for several diseases, including neurodegenerative diseases.

Conclusion

In conclusion, POTI (Protein Tyrosine Kinase-Associated with DNA Binding II) is a key regulator of gene expression and has been implicated in various diseases including cancer, neurodegenerative diseases, and autoimmune disorders. The regulation of DNA binding by POTI is a complex process that involves multiple interactions with various protein substrates and signaling proteins.

Targeting POTI with drugs has the potential to treat various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the regulation of DNA binding by POTI and to develop effective drugs that target this protein.

Protein Name: POTE Ankyrin Domain Family Member I

The "POTEI Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POTEI comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets